panitumumab-IRDye800
Term · Oncology and biomedicine · MLC-T-ONC-015795
An imaging agent composed of panitumumab, a humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody, conjugated to the near-infrared (NIR) fluorescent dye IRDye800, that can potentially be used for the imaging of EGFR-expressing tumors. Upon administration of panitumumab-IRDye800, the panitumumab moiety targets and binds to EGFR expressed on tumor cells. Upon fluorescence imaging of IRDye800, the tumor cells can be detected.
| Identifier | MLC-T-ONC-015795 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | panitumumab IRDye 800; IRDye800-panitumumab conjugate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015795",
"term": "panitumumab-IRDye800",
"field": "Oncology and biomedicine",
"definition": "An imaging agent composed of panitumumab, a humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody, conjugated to the near-infrared (NIR) fluorescent dye IRDye800, that can potentially be used for the imaging of EGFR-expressing tumors. Upon administration of panitumumab-IRDye800, the panitumumab moiety targets and binds to EGFR expressed on tumor cells. Upon fluorescence imaging of IRDye800, the tumor cells can be detected.",
"synonyms": [
"panitumumab IRDye 800",
"IRDye800-panitumumab conjugate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/panitumumab-irdye800/"
}
Record 12,584 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.